NDC properties for NDC 9 55513-479
NDC item 55513047901
| NDC 9 | 55513-479 |
|---|---|
| NDC 10 | 55513-479-01 |
| NDC Item | 55513047901 |
| packaging | 1 SYRINGE in 1 CARTON (55513-479-01) / .4 mL in 1 SYRINGE |
| BLA | BLA761024 |
| Labeler | Amgen, Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-08-14 |
| Marketing status | ACTIVE |
NDC item 55513047902
| NDC 9 | 55513-479 |
|---|---|
| NDC 10 | 55513-479-02 |
| NDC Item | 55513047902 |
| packaging | 2 SYRINGE in 1 CARTON (55513-479-02) / .4 mL in 1 SYRINGE |
| BLA | BLA761024 |
| Labeler | Amgen, Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-08-14 |
| Marketing status | ACTIVE |
NDC item 72511047901
| NDC 9 | 72511-479 |
|---|---|
| NDC 10 | 72511-479-01 |
| NDC Item | 72511047901 |
| BLA | BLA761024 |
| Labeler | Amgen USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2024-11-08 |
| Marketing status | ACTIVE |
NDC item 72511047902
| NDC 9 | 72511-479 |
|---|---|
| NDC 10 | 72511-479-02 |
| NDC Item | 72511047902 |
| packaging | 2 SYRINGE in 1 CARTON (72511-479-02) / .4 mL in 1 SYRINGE |
| BLA | BLA761024 |
| Labeler | Amgen USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2024-11-08 |
| Marketing status | ACTIVE |
NDC item 84612047901
| NDC 9 | 84612-479 |
|---|---|
| NDC 10 | 84612-479-01 |
| NDC Item | 84612047901 |
| packaging | 1 SYRINGE in 1 CARTON (84612-479-01) / .4 mL in 1 SYRINGE |
| BLA | BLA761024 |
| Labeler | Nuvaila Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2025-01-01 |
| Marketing status | ACTIVE |
NDC item 84612047902
| NDC 9 | 84612-479 |
|---|---|
| NDC 10 | 84612-479-02 |
| NDC Item | 84612047902 |
| packaging | 2 SYRINGE in 1 CARTON (84612-479-02) / .4 mL in 1 SYRINGE |
| BLA | BLA761024 |
| Labeler | Nuvaila Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2025-01-01 |
| Marketing status | ACTIVE |